HEALIOS INC. TERMS AND CONDITIONS FOR FIRST CLINICAL TRIAL

Healios, Inc. (“MyHealios” or “we” or “us”) is committed to protecting and respecting your privacy. This Privacy Policy (together with our website Terms of Use) sets forth the terms and restrictions pertaining to the personal information we may collect from you on our website, or that you provide to us through this website, and which is used, handled and maintained by us. Please read the following Privacy Policy carefully to understand our practices regarding your personal data and how we will treat it. By accessing the MyHealios website at www.myhealios.org/clinicaltrials/janssen, including all related pages, as well as our telephone services, you are accepting the practices as outlined in this Privacy Policy Statement. If you decide to visit the MyHealios/Janssen clinical trial site, your visit and any possible dispute over privacy is subject to this Privacy Policy and our Terms & Conditions, including limitations on damages, adjudication of disputes, and application of US and local law. This website is intended for use by residents of the United States only.

If you do not agree to the terms of our Privacy Policy, please discontinue your use, and advise us of your specific objections, questions and concerns.

1. INFORMATION YOU PROVIDE TO US

1.1 We may collect and process the following identifying in formation about you on our website: 
1.1.1 information that you provide by filling in forms on our site. This includes information requested at the time of registering to use our site, booking a service or requesting further services; 
1.1.2 if you contact MyHealios, we may keep a record of that correspondence; 
1.1.3 details of your visits to our website including, but not limited to, traffic data, location data, weblogs and other communication data, and the resources that you access.

2. IP ADDRESSES

2.1 We may collect and store information about your computer, including where available your IP address, operating system and browser type, for system administration and to report aggregate information. This is statistical data about users' browsing actions and patterns, and does not identify any individual.

3. COOKIES

3.1 Our website may use tracking cookies to distinguish you from other users of our website. This helps us to provide you with a more personalized and welcoming experience when you browse our website, and also allows us to continually improve our site. MyHealios employs cookies in order for its server to recognize a return visitor as a unique user. The cookies placed by the MyHealios server are readable only by us, and cookies cannot access, read or modify any other data on a computer. The "help" portion of the toolbar on most browsers will instruct you on how to prevent your browser from accepting new cookies, how to command the browser to tell you when you receive a new cookie, or how to fully disable cookies. We strongly recommend that you leave the cookies activated, however, because cookies enable you to take advantage of most of MyHealios's most important features and functionality.

3.2 We may use the following cookies: 
3.2.1 Operationally required cookies. These are cookies that are required for the operation of our website. They include, for example, cookies that enable you to log into secure areas of our website or make use of e-billing services.

3.3 Please note that third parties (including, for example, advertising networks and providers of external services like web traffic analysis services) may also use cookies, over which we have no control. These cookies are likely to be analytical/performance cookies or targeting cookies.

3.4 You may block cookies by activating the settings on your browser that allows you to refuse the use of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or parts of our site.

4. WHERE WE STORE YOUR PERSONAL DATA

4.1 The data that we collect from you is stored and processed within the United States. We will take all steps reasonably necessary to ensure that your data is treated securely and in accordance with this Privacy Policy.

4.2 Unfortunately, the transmission of information via the Internet cannot be expected to be completely secure. Although we will do our best to protect your personal information, we cannot guarantee the security of your data transmitted to our site, and any transmission is ultimately at your own risk. Once we have received your information, we will use strict procedures and security features to try to prevent unauthorized access.

5. USES MADE OF THE INFORMATION

5.1 We use information held about you in the following ways: 
5.1.1 to ensure that content from our site is presented in the most effective manner for you and for your computer; 
5.1.2 to provide you with information, products or services that you request from us where you have consented to be contacted for such purposes; 
5.1.3 to carry out our obligations arising from any contracts entered into between you and us; 
5.1.4 to notify you about changes to our service.

5.2 We do not disclose information about identifiable individuals, but we may provide third parties with aggregate information about our users (both website users and users of the MyHealios Telephone Service) to analyze for various purposes, including improving service content and delivery, or outcomes analysis. Where we provide aggregated information, information about identifiable individuals will not be identifiable within the aggregated data.

6. INFORMATION WE MAY COLLECT FROM YOU VIA THE MYHEALIOS SERVICE AS PART OF THE FIRST CLIICAL TRIAL

We provide a telephone or web conferencing-based service designed to educate, train and support caregivers in their support and communication to schizophrenia sufferers (the “MyHealios Service”) as part of the FIRST Clinical Trial. This Privacy Policy does not govern the use of personal data that we may collect from you through the MyHealios telephone services with the FIRST Clinical Trial. For details as to how we may collect and process data provided by you through the MyHealios services, please see our terms of use for the MyHealios Service here

7. DISCLOSURE OF YOUR INFORMATION

7.1 We may disclose your personal information to third parties: 
7.1.1 in the event that we sell or buy any business or assets, in which case we may disclose your non-identifiable personal data to the prospective seller or buyer of such business or assets; 
7.1.2 if MyHealios or substantially all of its assets are acquired by a third party, in which case non-identifiable personal data held by it about its customers will be one of the transferred assets.

7.2 If we are under a duty to disclose or share your personal data in order to comply with any legal obligation, or in order to enforce or apply our terms of website use or our terms of telephone service use; or to protect the rights, property, or safety of MyHealios. This includes exchanging information with other companies and organisations for the purposes of fraud protection and credit risk reduction.

8. YOUR RIGHTS

8.1 Our site may, from time to time, contain links to and from the websites of our partner networks, advertisers and affiliates. If you follow a link to any of these websites, please note that these websites have their own privacy policies, and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.

9. CONFIDENCIALTY

MyHealios has implemented procedures to reasonably protect data security and the use and disclosure of Identifiable Information. "Identifiable Information" means information which reveals the identity of the participant or reasonably could be used to identify the participant. MyHealios protects the identity of participants in the FIRST Clinical Trial; MyHealios does not disclose Identifiable Information unless the participant has permitted such disclosure or it is allowed or required by law. MyHealios has implemented procedures designed to protect the privacy and security of Identifiable Information, which procedures are described here. MyHealios uses and discloses Identifiable Information only as appropriate under and described in this Policy Statement. MyHealios stores or maintains Identifiable Information obtained in the course of administering its services and in its research programs in secure locations and limits access to Identifiable Information to workforce members and third parties that need to have such access in order to achieve only these specific purposes. MyHealios' workforce members use and disclose Identifiable Information only as described in this Policy or as permitted or required by law. When MyHealios receives Identifiable Information from sources other than the participant or user, MyHealios enters into confidentiality agreements with the entity(ies) that provide such information to MyHealios. Those confidentiality agreements require protections at least as stringent as those described in this Policy. MyHealios enters into confidentiality agreements with subcontractors and other third parties to which MyHealios provides Identifiable Information. Those confidentiality agreements require the third parties to implement protections for the privacy and security of such information at least as stringent as those described in this Policy. Prior to providing research results to clients, MyHealios removes Identifiable Information. At the conclusion of each research program, MyHealios uses reasonable efforts to destroy or de-identify (make anonymous) all Identifiable Information, unless the participant has agreed to be re-contacted about future research programs or MyHealios is otherwise required by contract or permitted or required by law to maintain such information. MyHealios does not and would not knowingly use or disclose Identifiable Information in violation of any privacy or security law or agreement. If we are ordered to use or disclose Identifiable Information in a legal proceeding, MyHealios will take reasonable steps within the context of that legal proceeding to inform the court or other decision-maker of the confidentiality of the information, and MyHealios will take reasonable steps to otherwise maintain the confidentiality of such information. MyHealios uses reasonable and appropriate safeguards to protect the security of Identifiable Information, including specifically the confidentiality and integrity of such information.

10. CHANGES TO OUR PRIVACY POLICY

10.1 MyHealios reserves the right, and may amend this Privacy Policy as part of the FIRST Clinical Trial. Use of information we collect is subject to the Privacy Policy in effect at the time such information is used. If we make changes to our privacy policy, we will notify you by posting the revised notice on our Site and/or sending you an email so you are always aware of what information we collect, how we use it and under what circumstances if any, it is disclosed.

11. QUESTIONS AND CONCERNS

11.1 Questions, comments and requests regarding this privacy policy are welcomed and should be addressed toThis email address is being protected from spambots. You need JavaScript enabled to view it.. Ensuring your privacy is very import to us, and we will make every effort to answer any questions which you may have and to resolve your concerns.